How Does a Dry-Eye Doctor Choose the Right Treatment?

A dry eye doctor chooses treatment by first confirming the diagnosis and then identifying the specific tear film, eyelid, ocular surface and systemic factors contributing to the condition.

The goal is not simply to select a stronger artificial tear or follow the same treatment sequence for every patient. It is to match each treatment to the clinical findings it is intended to address.

Because dry eye is frequently caused by several interacting factors, an effective plan may combine home care, prescription medication, tear film support and in office procedures. The plan may also need to be adjusted over time according to the patient’s response.

Why Isn’t There One Best Dry Eye Treatment?

Dry eye is a multifactorial disease. Two people can experience similar burning, watering, grittiness or fluctuating vision while having very different underlying problems.

One patient may have obstructed meibomian glands and rapid tear evaporation. Another may have inadequate aqueous tear production. A third may have eyelid inflammation, incomplete eyelid closure, corneal damage or abnormal nerve signaling.

Many patients have several of these problems simultaneously.

A treatment that is effective for one person may provide little benefit to another if it does not address the same etiological drivers. This is why treatment selection begins with a comprehensive evaluation rather than a predetermined list of products or procedures.

Learn more: What Causes Dry Eye?

Step 1: Confirm That the Symptoms Are Caused by Dry Eye

Burning, redness, tearing and blurry vision can occur with dry eye, but they can also be caused by other conditions.

A dry eye doctor must consider whether the symptoms could be related to:

• Allergic conjunctivitis
• Anterior or Demodex blepharitis
• Eye infection
• Contact lens complications
• Tear drainage obstruction
• Corneal injury or recurrent erosion
• Eyelid malposition
• Neurotrophic keratitis
• Neuropathic ocular pain
• Medication toxicity
• Previous eye surgery
• Another ocular surface disorder

Current TFOS DEWS III guidance requires both symptoms and objective evidence of disrupted tear film or ocular surface homeostasis to diagnose dry eye disease.

When symptoms are severe but visible clinical findings are limited, a neurosensory or neuropathic component may need to be considered. When significant corneal damage is present with few symptoms, reduced corneal sensation or neurotrophic disease may require evaluation.

The correct treatment depends on distinguishing among these possibilities.

Step 2: Identify the Etiological Drivers

At EnVision Dry Eye Center, Dr. Jason Besecker combines the patient’s history and symptoms with detailed examination and objective testing.

Diagnostic testing may include:

• Meibography
• Noninvasive tear breakup time measurement
• Tear osmolarity testing
• Fluorescein staining
• High resolution slit-lamp examination and imaging
• Evaluation of the eyelids, eyelashes and blink
• Assessment of meibomian gland secretions
• Evaluation of eyelid position and closure
• Corneal sensation testing when indicated

These findings help determine what is disrupting the tear film or ocular surface and which treatments are most likely to address those abnormalities.

Learn more: What Happens During a Comprehensive Dry Eye Evaluation?

How Does TFOS DEWS III Guide Treatment Selection?

TFOS DEWS III organizes dry eye disease according to etiological drivers rather than relying only on the older division between aqueous deficient and evaporative dry eye.

The primary driver categories include:

• Tear component deficiencies
• Eyelid abnormalities
• Ocular-surface abnormalities
• Systemic and external contributors

These categories can overlap. Treatment may need to target several drivers at the same time to restore tear film and ocular surface homeostasis.

How Are Tear Component Deficiencies Treated?

The tear film contains lipid, aqueous, and mucin or glycocalyx components. Treatment depends on which components are deficient or unstable.

Lipid Deficiency

The lipid layer slows tear evaporation and is produced primarily by the meibomian glands. When the glands are obstructed or produce poor quality oil, the tear film may evaporate too quickly.

Depending on the findings, treatment may include:

• An individualized eyelid hygiene routine
• Warm compresses when appropriate
• Lipid containing or evaporation reducing eye drops
• Prescription treatment for associated inflammation
• Treatment of ocular rosacea
• Thermal meibomian gland treatment
• Intense Pulsed Light therapy
• Tixel thermomechanical treatment
• TearCare
• Red light therapy

Device based treatment is not selected solely because a patient has dry eye symptoms. Meibography, gland expression, eyelid findings and previous treatment response help determine whether a particular procedure is appropriate.

Learn more: What Is Meibomian Gland Dysfunction?

Aqueous Tear Deficiency

Some patients do not produce an adequate volume of the watery component of the tear film. This may occur with aging, Sjögren’s disease, medication use, hormonal changes, lacrimal-gland dysfunction or other systemic conditions.

Treatment may include:

• Preservative free artificial tears
• Gels or ointments
• Prescription medications that reduce inflammation or support tear production
• Moisture chamber glasses or sleep masks
• Punctal plugs
• LacriFill canalicular filler
• Autologous serum tears
• Platelet rich plasma tears

The timing of tear conservation procedures depends on the condition of the ocular surface, tear quality and other contributing factors. Punctal occlusion is not automatically appropriate for every patient with dry eye symptoms.

Mucin or Glycocalyx Abnormalities

Mucins and the glycocalyx help tears spread evenly and remain attached to the ocular surface. When these structures are disrupted, tears may not adequately coat or protect the eye.

Treatment selection may involve:

• Preservative free tear supplementation
• Treatment of ocular surface inflammation
• Management of associated allergy or medication toxicity
• Biologic tear therapy
• Protection and rehabilitation of damaged epithelial cells
• Correction of anatomical abnormalities that interfere with tear distribution

These abnormalities are evaluated together with the corneal and conjunctival examination rather than through symptoms alone.

How Are Eyelid Abnormalities Treated?

The eyelids create, distribute and conserve important parts of the tear film. Eyelid disease can therefore remain an important driver even when a patient is using artificial tears regularly.

Meibomian Gland Dysfunction

Treatment is selected according to gland structure, obstruction, secretion quality, inflammation and disease severity.

A plan may combine daily care, prescription therapy and an in office procedure. Advanced gland loss seen on meibography may also influence expectations because treatment cannot regenerate glands that have been permanently lost.

Anterior Blepharitis

Anterior blepharitis affects the eyelid margins, eyelashes and eyelash follicles.

Treatment may include:

• Appropriate daily eyelid cleansing
• In office eyelid debridement with BlephEx
• Topical antimicrobial treatment when indicated
• Short term anti-inflammatory treatment when appropriate
• Management of associated skin disease

Learn more: What Is Anterior Blepharitis?

Demodex Blepharitis

Demodex blepharitis is caused by an excessive number of Demodex mites around the eyelashes and eyelid glands.

When characteristic collarettes and other findings confirm Demodex, treatment should be directed at the mites. Artificial tears may reduce irritation temporarily but do not treat the infestation.

Treatment may include:

• Appropriate daily eyelid cleansing
• In office eyelid debridement with BlephEx
• Topical prescription antiparasitic treatment when indicated
• Short term anti-inflammatory treatment when appropriate
• Management of associated skin disease (ie Rosacea)

Incomplete Blinking or Eyelid Closure

Reduced blink frequency, incomplete blinking and inadequate eyelid closure can expose the ocular surface and increase evaporation.

Treatment may include:

• Blink training or changes in screen habits
• Lubricating ointment at night
• Moisture chamber goggles or sleep masks
• Protection from direct airflow
• Treatment of associated eyelid disease
• Procedures to correct eyelid position in selected cases

A patient whose eyes are exposed during sleep requires a different plan from someone whose primary problem is meibomian gland obstruction.

How Are Ocular Surface Abnormalities Treated?

The cornea and conjunctiva must remain healthy for the tear film to spread properly and for the eyes to feel comfortable.

Ocular-Surface Inflammation

Inflammation may both result from and perpetuate tear film instability.

Depending on its severity and cause, treatment may include:

• Preservative free lubrication
• Prescription anti-inflammatory eye drops
• Carefully monitored short-term corticosteroid treatment
• Management of meibomian gland dysfunction or ocular rosacea
• Environmental and lifestyle modification
• Treatment of associated infection, allergy or medication toxicity

Anti-inflammatory treatments do not all work at the same speed. Some provide relatively rapid control, while others require consistent use over a longer period.

Corneal or Conjunctival Damage

When the ocular surface has substantial epithelial damage, treatment may need to provide more than temporary lubrication.

Selected options may include:

• Autologous serum tears
• Platelet rich plasma tears
• Amniotic tissue contact lenses, including PROKERA
• Protective contact lenses when appropriate
• Treatment of exposure or neurotrophic disease
• Superficial keratectomy or another corneal procedure when structural disease is present

Biologic and regenerative therapies are generally chosen according to the severity and type of ocular surface damage. They are not automatically required for every patient with chronic symptoms.

Anatomical Abnormalities

Physical changes can interfere with tear distribution, tear clearance or eyelid function.

Examples include:

• Conjunctivochalasis
• Superior limbic keratoconjunctivitis
• Eyelid malposition
• Floppy eyelid syndrome
• Anterior basement membrane dystrophy
• Recurrent corneal erosion

Treatment may begin with lubrication and inflammation control. When an anatomical abnormality continues to disrupt the tear film or damage the ocular surface, a procedure such as plasma pen conjunctivoplasty, superficial keratectomy or anterior stromal micropuncture may be considered for an appropriately selected patient.

Neurosensory Abnormalities

The corneal nerves help regulate tear production, blinking and ocular sensation.

Reduced nerve function can contribute to neurotrophic keratitis, in which significant damage may occur with surprisingly few symptoms. Abnormally amplified nerve signaling can cause severe burning, pain or light sensitivity despite relatively limited visible findings.

These conditions require different treatment strategies. A therapy intended for tear evaporation alone may not adequately address a significant neurosensory component.

Evaluation may include corneal sensation testing, review of pain characteristics and consideration of migraine, chronic pain, previous surgery or nerve injury. Coordination with another medical specialist may be appropriate in selected cases.

How Are Systemic and External Contributors Addressed?

Dry eye treatment sometimes requires attention to factors outside the eye.

Potential contributors include:

• Sjögren’s disease and other autoimmune disorders
• Diabetes
• Menopause and hormonal changes
• Rosacea and dermatologic disease
• Thyroid disease
• Migraine and chronic pain conditions
• Prescription and over the counter medications
• Contact lens wear
• Previous eye surgery
• Extended screen use
• Low humidity, wind, fans or heating and cooling vents
• Poor sleep or sleep related eyelid exposure

Treatment may involve modifying controllable environmental factors, addressing associated ocular surface findings and coordinating care with a primary care physician, rheumatologist, dermatologist, endocrinologist or another specialist.

Patients should not discontinue a prescribed systemic medication without first discussing it with the clinician who prescribed it.

How Does a Doctor Decide Which Treatment to Start First?

When several abnormalities are present, the treatment plan must be prioritized.

Factors that may influence the order of treatment include:

• The findings most likely to be causing the symptoms
• The presence and severity of ocular surface damage
• Whether vision is being affected
• The risk of disease progression
• The degree of eyelid or meibomian gland dysfunction
• The presence of active inflammation or infection
• Previous treatment response
• Medical history and contraindications
• Contact lens use or upcoming eye surgery
• The patient’s daily routine, treatment tolerance and goals
• The strength of the evidence supporting each option

The most advanced procedure is not necessarily the correct first treatment. The best starting point is the intervention that most directly addresses the important clinical findings while remaining safe and practical for the patient.

Why Might Several Treatments Be Recommended?

Dry eye subtypes are not mutually exclusive.

A patient may simultaneously have:

• Meibomian gland dysfunction
• Anterior blepharitis
• Incomplete eyelid closure
• Elevated tear osmolarity
• Ocular surface inflammation
• Corneal staining

Treating only one component may provide incomplete relief. A combination plan may be needed to improve tear quality, reduce inflammation, protect the ocular surface and address the eyelid abnormality.

This does not mean every treatment must begin at once. Dr. Besecker may introduce treatments in a deliberate sequence so that safety, tolerance and response can be evaluated.

Why Are Artificial Tears Often Not Enough?

Artificial tears can supplement moisture, improve lubrication and provide temporary relief. However, they do not correct every cause of dry eye.

Artificial tears cannot independently:

• Open obstructed meibomian glands
• Eliminate Demodex mites
• Correct incomplete eyelid closure
• Resolve significant ocular surface inflammation
• Repair every anatomical abnormality
• Reverse advanced meibomian gland loss
• Correct abnormal corneal nerve signaling

When an underlying driver remains untreated, relief from artificial tears may be brief or incomplete.

Learn more: Why Aren’t Artificial Tears Helping My Dry Eyes?

How Does the Doctor Know Whether Treatment Is Working?

Dry eye treatment is monitored using the patient’s experience and objective clinical findings.

At follow up visits, the doctor may assess:

• Changes in burning, grittiness, tearing or pain
• Visual stability
• Ability to tolerate reading, screens or contact lenses
• Tear breakup time
• Tear osmolarity
• Corneal and conjunctival staining
• Eyelid margin inflammation
• Meibomian gland secretions
• Adherence and tolerance
• Any side effects or new symptoms

Symptoms and test results do not always improve at the same rate. A patient may notice improved comfort before all clinical signs resolve, or the ocular surface may improve before the patient experiences substantial symptom relief.

Treatment may be continued, modified or expanded according to these findings.

How Long Does It Take to Find the Right Treatment Plan?

The timeline varies according to the underlying drivers, disease duration and severity.

Some treatments provide relief relatively quickly. Others require consistent use for weeks or months before their full effect can be evaluated. Chronic gland obstruction, significant inflammation, advanced ocular surface damage and neurosensory abnormalities may require longer term management.

Finding the right treatment plan does not always mean selecting one permanent therapy at the first visit. It may involve:

• Identifying the most important drivers.
• Beginning targeted treatment.
• Allowing adequate time for the treatment to work.
• Reassessing symptoms and clinical findings.
• Adjusting the plan when necessary.

Dry eye management is often an ongoing process rather than a single procedure or prescription.

What Questions Should I Ask About a Recommended Treatment?

Patients should understand why a treatment is being recommended.

Helpful questions include:

• Which examination finding is this treatment intended to address?
• Is the treatment targeting my tear film, eyelids, ocular surface or another contributor?
• What improvement should I reasonably expect?
• How long should I use the treatment before evaluating the response?
• What are the potential risks or side effects?
• Are there alternative options?
• Will I need ongoing maintenance?
• How will we determine whether the treatment is working?

​​​​​​​A clear treatment plan should connect each recommendation to a specific clinical finding or therapeutic goal.

Schedule a Comprehensive Dry Eye Evaluation

Selecting the right dry eye treatment begins with determining what is disrupting your tear film and ocular surface.

At EnVision Dry Eye Center, Dr. Jason Besecker uses detailed examination and objective diagnostic testing to identify the contributing factors and develop an individualized treatment plan.

EnVision Dry Eye Center
3752 E Amity Avenue, Suite 103
Nampa, Idaho 83687
Call (208) 490-8823

Request a Comprehensive Dry-Eye Evaluation

Medically reviewed by Jason Besecker, OD, MS
Last updated: October 2026

Explore Dry Eye Questions & Answers

​​​​​​​Clinical References

• TFOS DEWS III: Management and Therapy
• TFOS DEWS III: Diagnostic Methodology
• TFOS DEWS III: Executive Summary